Accession PRJCA011167
Title A Randomized, Double-Blind, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of BAT1806 to RoActemra in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
Relevance Medical
Data types Random survey
Organisms Homo sapiens
Description The primary objective of the study is to demonstrate equivalent efficacy of BAT1806 and RoActemra in subjects with rheumatoid arthritis (RA) that is inadequately controlled by methotrexate (MTX).
Sample scope Multiisolate
Release date 2022-08-12
Grants
Agency program Grant ID Grant title
Bio-Thera Solutions, Ltd. 2017L04937 A Randomized, Double-Blind, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of BAT1806 to RoActemra in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
Submitter Xiaofeng Zeng (xiaofeng.zeng@cstar.org.cn)
Organization Peking Union Medical College Hospital,
Submission date 2022-08-12

Project Data

Resource name Description